TCI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

TCI şirketinin toplam hissedar öz sermayesi NT$8.9B ve toplam borcu NT$1.4B olup, bu da borç-öz sermaye oranını 15.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NT$14.1B ve NT$5.2B dir. TCI 'in FAVÖK'ü NT$1.0B faiz karşılama oranı -22.2 dur. Şirketin NT$5.6B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

15.6%

Borç/özkaynak oranı

NT$1.39b

Borç

Faiz karşılama oranı	-22.2x
Nakit	NT$5.63b
Eşitlik	NT$8.90b
Toplam yükümlülükler	NT$5.17b
Toplam varlıklar	NT$14.08b

Son finansal sağlık güncellemeleri

We Think TCI (GTSM:8436) Can Stay On Top Of Its Debt

Jan 21

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 8436 'nin kısa vadeli varlıkları ( NT$7.9B ) kısa vadeli yükümlülüklerini ( NT$4.2B ) aşıyor.

Uzun Vadeli Yükümlülükler: 8436 şirketinin kısa vadeli varlıkları ( NT$7.9B ) uzun vadeli yükümlülüklerini ( NT$987.6M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 8436 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 8436 şirketinin borç/öz sermaye oranı son 5 yılda 6.7% seviyesinden 15.6% seviyesine yükseldi.

Borç Kapsamı: 8436 'nin borcu işletme nakit akışı ( 112.1% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 8436 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

TCI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

We Think TCI (GTSM:8436) Can Stay On Top Of Its Debt

Recent updates

Consensus EPS estimates increase by 13%

TCI Co., Ltd. Unveils Promising GLP-1 Formula Clinical Trial Results for Advanced Weight Management

TCI Co., Ltd. to Report Q2, 2024 Results on Jul 30, 2024

Dividend of NT$7.00 announced

New major risk - Revenue and earnings growth

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

Consensus EPS estimates increase by 16%

First quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% overvalued

TCI Co., Ltd. Board Approves Dividend Distribution for the Year Ended December 31, 2023

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Consensus revenue estimates fall by 12%

Full year 2023 earnings: EPS and revenues miss analyst expectations

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

TCI Co., Ltd. Unveils Weight Loss Formula at SupplySide West 2023

Upcoming dividend of NT$5.02 per share at 4.8% yield

TCI Co., Ltd. Announces Cash Dividend, Payable on August 22, 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

TCI Introduces Vecollal

TCI Introduces Vecollal

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

Consensus EPS estimates fall by 26%

TCI Co., Ltd. Announces Cash Dividend for the Year Ended December 31, 2022

Now 22% undervalued

Now 20% undervalued

Price target increased by 11% to NT$179

Consensus forecasts updated

Price target increased to NT$177

Investor sentiment improved over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

TCI Co., Ltd. Announces Executive Changes

Consensus EPS estimates fall by 31%

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of NT$8.92 per share

TCI Co., Ltd. Approves Cash Dividend, Payable on August 18, 2022

Price target decreased to NT$183

TCI Co., Ltd. Appoints Members of the Risk Management Committee

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Price target decreased to NT$197

TCI Co., Ltd., Annual General Meeting, Jun 29, 2022

Price target decreased to NT$197

Consensus EPS estimates fall by 13%

Price target decreased to NT$258

Price target decreased to NT$278

Price target decreased to NT$283

Third quarter 2021 earnings released: EPS NT$4.02 (vs NT$4.23 in 3Q 2020)

Upcoming dividend of NT$8.88 per share

Second quarter 2021 earnings released: EPS NT$4.19 (vs NT$4.50 in 2Q 2020)

Investor sentiment improved over the past week

TCI Co., Ltd. (TPEX:8436) entered into a memorandum of understanding to acquire US manufacturing operations from NewAge, Inc. (NasdaqCM:NBEV) for $3.5 million.

Head of Finance Department & CFO Chia- Chi Li has left the company

Price target increased to NT$249

Price target increased to NT$240

First quarter 2021 earnings released: EPS NT$3.25 (vs NT$3.13 in 1Q 2020)

Is TCI Co., Ltd. (GTSM:8436) A Smart Choice For Dividend Investors?

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Analysts lower EPS estimates to NT$15.17

TCI Co., Ltd. (GTSM:8436) made an offer to acquire 30% stake in Maxigen Biotech Inc. (TSEC:1783) for approximately TWD 600 million.

Price target lowered to NT$235

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Revenue and earnings miss expectations

New 90-day high: NT$221

Is TCI's (GTSM:8436) 160% Share Price Increase Well Justified?

We Think TCI (GTSM:8436) Can Stay On Top Of Its Debt

New 90-day low: NT$197

Is TCI (GTSM:8436) The Next Multi-Bagger?

New 90-day low: NT$209

Did You Participate In Any Of TCI's (GTSM:8436) Incredible 308% Return?